Brief: PAVmed Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule
30/07/2025 13:56
July 30 (Reuters) - PAVmed Inc PAVM.O: PAVMED GRANTED 180-DAY EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE RULE Source text: ID:nPn5yYHWZa Further company coverage: PAVM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PAVmed
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
PAVmed Inc reports results for the quarter ended June 30 - Earnings Summary
PAVmed Inc expected to post a loss of 47 cents a share - Earnings Preview
NASDAQ RESUMED AT 11:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:21 AM